Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimi HealthOPTHF 4 Gross Margin % is 89.04% as of Mar. 2026, which is 31% above its 10-year median of 68.08. GuruFocus rates OPTHF with a GF Score™ of 4/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 943 Drug Manufacturers companies, Optimi Health ranks worse than 99.26% on this metric.
The historical rank and industry rank for Optimi Health's Gross Margin % or its related term are showing as below:
OPTHF'
s Gross Margin % Range Over the Past 10 Years
Min: -83.19 Med: 68.08 Max: 110.5
Current: -83.19
During the past 6 years, the highestGross Margin % of Optimi Health was 110.50%. The lowest was -83.19%. And the median was 68.08%.
OPTHF's Gross Margin % is ranked worse than 99.26% of 943
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs OPTHF: -83.19
Optimi Health had a gross margin of 89.04% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Optimi Health was 0.00% per year.
Optimi Health (OTCPK:OPTHF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Optimi Health had a gross margin of 89.04% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Optimi Health Gross Margin % Related Terms
Optimi Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for Optimi Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimi Health Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Optimi Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Optimi Health (OPTHF) has a Gross Margin % of 89.04% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Optimi Health and its competitors. This is 31% above median its historical median of 68.08. According to the industry distribution chart, Optimi Health ranks #936 out of 943 companies in the Drug Manufacturers industry, placing it in the top 99.3%.
Is Optimi Health's Gross Margin % too high?
Optimi Health's current Gross Margin % of 89.04% is 31% above median its 10-year median of 68.08. The Drug Manufacturers industry median Gross Margin % is 48.54. Optimi Health's value of 89.04% is 83.4% above this industry median. Based on the distribution chart, Optimi Health ranks #936 out of 943 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Optimi Health has a GF Score™ of 4/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #936 out of 943 companies for Gross Margin %. This places Optimi Health in the lower half of its industry. The industry median Gross Margin % is 48.54. Optimi Health's value of 89.04% is 83.4% above this benchmark. While the company's 10-year median is 68.08 vs. the industry median of 48.54, Optimi Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimi Health's current Gross Margin % of 89.04% is 83.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Optimi Health and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimi Health's current Gross Margin % is 89.04%, which is 31% above median its own 10-year median of 68.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (OPTHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $0.24 — trading 56.8% above its estimated fair value. The current Gross Margin % is 89.04%, which is 31% above median its 10-year median of 68.08 and 83.4% above the Drug Manufacturers industry median of 48.54. Optimi Health's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Optimi Health (OPTHF), the current Gross Margin % is 89.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimi Health (OPTHF) Overvalued in 2026?
Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued.
The current stock price of $0.24 is trading 56.8% above its estimated GF Value™ of $0.15.
GuruFocus considers Optimi Health to be Significantly Overvalued.
Key valuation signals for OPTHF:
Gross Margin %: 89.04% (31% above median its 10-year median of 68.08)
GF Value™: $0.15 vs. price of $0.24 (56.8% above fair value)
Industry Position: 83.4% above the Drug Manufacturers median (#936 of 943)
No single metric tells the full story. See the OPTHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
4GF Score
Get the complete analysis for OPTHF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTHF has been successfully added to your 
